Bull Case

A sustained recovery in semiconductor test demand, led by advanced packaging and AI-related device ramps, lifts AEHR’s wafer-level burn-in utilization faster than peers.

Higher customer concentration in a few large silicon carbide and logic programs converts into outsized revenue leverage, while smaller test-equipment peers recover more gradually.

Improved gross margin from better factory absorption and a richer mix of consumables and services narrows operating losses, offsetting AEHR’s currently negative TTM margin.

If customers resume multi-quarter qualification and capacity expansion orders, backlog conversion improves and cash burn eases, supporting a stronger balance-sheet trajectory than leveraged peers.

Base Case

Demand normalizes unevenly as silicon carbide spending stabilizes but remains lumpy, leaving AEHR’s revenue below prior peaks and only modestly ahead of weaker analog-test peers.

Gross margin improves from trough levels as utilization recovers, yet operating profitability stays constrained because fixed costs remain high relative to current sales.

Customer ordering remains project-based rather than recurring, so quarterly volatility persists and limits multiple expansion versus more diversified semiconductor equipment peers.

Liquidity pressure eases only gradually because negative operating cash flow and elevated leverage keep financing flexibility tighter than for cash-rich test-equipment competitors.

Bear Case

A delayed capex recovery in silicon carbide and AI-adjacent semiconductor programs pushes AEHR’s revenue lower, while peers with broader end-market exposure recover first.

Low utilization keeps gross margin depressed and operating losses wide, worsening the already negative TTM operating margin and extending cash burn.

Customer concentration amplifies order timing risk, so one or two program delays can materially reduce shipments and backlog conversion versus more diversified peers.

With net debt already elevated and interest coverage effectively absent, weaker demand could force additional dilution or restrictive financing before operating leverage returns.

Overall Score

AEHR’s forward path is dominated by a cyclical demand recovery that can produce strong upside, but current leverage, losses, and customer concentration keep the most probable outcome only moderate.